The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 31, 2022
Filed:
Jun. 19, 2018
Applicant:
Wisconsin Alumni Research Foundation, Madison, WI (US);
Inventors:
Seungpyo Hong, Madison, WI (US);
Sin-Jung Park, Seoul, KR;
Assignee:
WISCONSIN ALUMNI RESEARCH FOUNDATION, Madison, WI (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 47/69 (2017.01); A61K 49/18 (2006.01); A61K 47/64 (2017.01); A61K 31/519 (2006.01); A61K 49/00 (2006.01); A61K 47/59 (2017.01); A61K 47/62 (2017.01); A61K 9/50 (2006.01); A61K 9/51 (2006.01); A61K 38/00 (2006.01); C07K 14/705 (2006.01); C12N 5/0775 (2010.01); C12N 5/09 (2010.01); B82Y 5/00 (2011.01);
U.S. Cl.
CPC ...
A61K 47/6905 (2017.08); A61K 9/5068 (2013.01); A61K 9/5146 (2013.01); A61K 31/519 (2013.01); A61K 47/595 (2017.08); A61K 47/62 (2017.08); A61K 47/64 (2017.08); A61K 47/6901 (2017.08); A61K 47/6935 (2017.08); A61K 49/0021 (2013.01); A61K 49/0043 (2013.01); A61K 49/0054 (2013.01); A61K 49/0056 (2013.01); A61K 49/0076 (2013.01); A61K 49/0093 (2013.01); A61K 49/0097 (2013.01); A61K 49/1806 (2013.01); A61K 49/1824 (2013.01); C07K 14/7055 (2013.01); C07K 14/70596 (2013.01); C12N 5/0662 (2013.01); C12N 5/0663 (2013.01); C12N 5/0693 (2013.01); A61K 38/00 (2013.01); B82Y 5/00 (2013.01); C12N 2509/00 (2013.01); C12N 2533/30 (2013.01);
Abstract
Described herein are hybrid nanoparticles that are exosomes loaded with one or more nanoparticle dendrimers. Also included are pharmaceutical compositions including the hybrid nanoparticles and methods of making the hybrid nanoparticles. Also described is a method of treating a human subject by administering to the human subject the above-described hybrid nanoparticles.